Glucagon‐like peptide‐1 receptor agonist inhibits aeroallergen‐induced activation of ILC2 and neutrophilic airway inflammation in obese mice

BACKGROUND: Obesity is a risk factor for the development of asthma. However, pharmacologic therapeutic strategies that specifically target obese asthmatics have not been identified. We hypothesize that glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) treatment inhibits aeroallergen‐induced early i...

Descripción completa

Detalles Bibliográficos
Autores principales: Toki, Shinji, Newcomb, Dawn C., Printz, Richard L., Cahill, Katherine N., Boyd, Kelli L., Niswender, Kevin D., Peebles, R. Stokes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597133/
https://www.ncbi.nlm.nih.gov/pubmed/33955007
http://dx.doi.org/10.1111/all.14879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597133/
https://www.ncbi.nlm.nih.gov/pubmed/33955007
http://dx.doi.org/10.1111/all.14879

Ejemplares similares